Drug Target Review

SEPTEMBER 10, 2024

The current landscape of protein drug development is characterised by accelerated timelines where new drugs are approved in months rather than years. In recent years, the biopharmaceutical industry has identified rapid Toxicology (Tox) material supply as the new critical path to IND readiness.

Drug Development 65

Drug Development Clinical Supply Production FDA 65

LifeSciVC

AUGUST 21, 2024

Drug development is a long process, and patients are waiting. For others this may serve as a reminder of some of the pitfalls that can befall biotech companies this time of year and what the key questions are to ask yourself and the team to manage through the madness and finish strong in 2024. Don’t get me wrong.

Clinical Trials 70

Clinical Trials Trials Disease Treatment 70

PPD

FEBRUARY 3, 2025

However, achieving this requires drug developers to navigate a highly complex and competitive environment. Delays in clinical trials can have significant financial consequences for sponsors. Recognized as the 2024 No. 1 provider of clinical research solutions , our teams deliver 1.5x

Clinical Trials 52

Clinical Trials Trials Clinical Supply Drug Development 52